Literature DB >> 25591736

LAMC2 enhances the metastatic potential of lung adenocarcinoma.

Y W Moon1, G Rao2, J J Kim3, H-S Shim4, K-S Park5, S S An6, B Kim7, P S Steeg8, S Sarfaraz9, L Changwoo Lee9, Donna Voeller9, E Y Choi6, Ji Luo9, D Palmieri8, H C Chung10, J-H Kim10, Y Wang5, G Giaccone5.   

Abstract

Lung cancer is the number one cancer killer, and metastasis is the main cause of high mortality in lung cancer patients. However, mechanisms underlying the development of lung cancer metastasis remain unknown. Using genome-wide transcriptional analysis in an experimental metastasis model, we identified laminin γ2 (LAMC2), an epithelial basement membrane protein, to be significantly upregulated in lung adenocarcinoma metastatic cells. Elevated LAMC2 increased traction force, migration, and invasion of lung adenocarcinoma cells accompanied by the induction of epithelial-mesenchymal transition (EMT). LAMC2 knockdown decreased traction force, migration, and invasion accompanied by EMT reduction in vitro, and attenuated metastasis in mice. LAMC2 promoted migration and invasion via EMT that was integrin β1- and ZEB1-dependent. High LAMC2 was significantly correlated with the mesenchymal marker vimentin expression in lung adenocarcinomas, and with higher risk of recurrence or death in patients with lung adenocarcinoma. We suggest that LAMC2 promotes metastasis in lung adenocarcinoma via EMT and may be a potential therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25591736      PMCID: PMC4495359          DOI: 10.1038/cdd.2014.228

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  53 in total

1.  Dynamic molecular changes associated with epithelial-mesenchymal transition and subsequent mesenchymal-epithelial transition in the early phase of metastatic tumor formation.

Authors:  Keiju Aokage; Genichiro Ishii; Yoichi Ohtaki; Yoko Yamaguchi; Tomoyuki Hishida; Junji Yoshida; Mitsuyo Nishimura; Kanji Nagai; Atsushi Ochiai
Journal:  Int J Cancer       Date:  2010-06-07       Impact factor: 7.396

2.  Expression of the gamma(2) chain of laminin-5 at the invasive front is associated with recurrence and poor prognosis in human esophageal squamous cell carcinoma.

Authors:  H Yamamoto; F Itoh; S Iku; M Hosokawa; K Imai
Journal:  Clin Cancer Res       Date:  2001-04       Impact factor: 12.531

3.  Fibrous stroma is associated with poorer prognosis in lung squamous cell carcinoma patients.

Authors:  Yusuke Takahashi; Genichiro Ishii; Tetsuhiko Taira; Satoshi Fujii; Shinya Yanagi; Tomoyuki Hishida; Junji Yoshida; Mitsuyo Nishimura; Hiroaki Nomori; Kanji Nagai; Atsushi Ochiai
Journal:  J Thorac Oncol       Date:  2011-09       Impact factor: 15.609

4.  Cytoplasmic expression of laminin gamma2 chain correlates with postoperative hepatic metastasis and poor prognosis in patients with pancreatic ductal adenocarcinoma.

Authors:  Shinichiro Takahashi; Takahiro Hasebe; Tatsuya Oda; Satoshi Sasaki; Taira Kinoshita; Masaru Konishi; Takenori Ochiai; Atsushi Ochiai
Journal:  Cancer       Date:  2002-03-15       Impact factor: 6.860

5.  Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion.

Authors:  Vasily Vasko; Allan V Espinosa; William Scouten; Huiling He; Herbert Auer; Sandya Liyanarachchi; Alexander Larin; Victoria Savchenko; Gary L Francis; Albert de la Chapelle; Motoyasu Saji; Matthew D Ringel
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-12       Impact factor: 11.205

6.  Motility induction in breast carcinoma by mammary epithelial laminin 332 (laminin 5).

Authors:  Philip M Carpenter; Anh V Dao; Zahida S Arain; Michelle K Chang; Hoa P Nguyen; Shehla Arain; Jessica Wang-Rodriguez; Soon-Young Kwon; Sharon P Wilczynski
Journal:  Mol Cancer Res       Date:  2009-04-07       Impact factor: 5.852

Review 7.  Tumour microenvironment: laminin 332 in squamous-cell carcinoma.

Authors:  M Peter Marinkovich
Journal:  Nat Rev Cancer       Date:  2007-05       Impact factor: 60.716

8.  Laminin-5γ2 chain expression is associated with tumor cell invasiveness and prognosis of lung squamous cell carcinoma.

Authors:  Ryota Masuda; Hiroshi Kijima; Naoko Imamura; Naohiro Aruga; Kenei Nakazato; Kana Oiwa; Takayuki Nakano; Hajime Watanabe; Yoichiro Ikoma; Makiko Tanaka; Sadaki Inokuchi; Masayuki Iwazaki
Journal:  Biomed Res       Date:  2012       Impact factor: 1.203

9.  A large cell-adhesive scatter factor secreted by human gastric carcinoma cells.

Authors:  K Miyazaki; Y Kikkawa; A Nakamura; H Yasumitsu; M Umeda
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

10.  Keratinocyte migration requires alpha2beta1 integrin-mediated interaction with the laminin 5 gamma2 chain.

Authors:  F Decline; P Rousselle
Journal:  J Cell Sci       Date:  2001-02       Impact factor: 5.285

View more
  40 in total

1.  Acquired SETD2 mutation and impaired CREB1 activation confer cisplatin resistance in metastatic non-small cell lung cancer.

Authors:  In-Kyu Kim; Justine N McCutcheon; Guanhua Rao; Stephen V Liu; Yves Pommier; Marcin Skrzypski; Yu-Wen Zhang; Giuseppe Giaccone
Journal:  Oncogene       Date:  2018-08-09       Impact factor: 9.867

2.  Laminin 332 expression and prognosis in breast cancer.

Authors:  Philip M Carpenter; Argyrios Ziogas; Emma M Markham; Alegria S Cantillep; Rui Yan; Hoda Anton-Culver
Journal:  Hum Pathol       Date:  2018-08-17       Impact factor: 3.466

3.  Epstein-Barr virus-induced ectopic CD137 expression helps nasopharyngeal carcinoma to escape immune surveillance and enables targeting by chimeric antigen receptors.

Authors:  Mukul Prasad; Sashigala Ponnalagu; Qun Zeng; Khang Luu; Si Min Lang; Hiu Yi Wong; Man Si Cheng; Meihui Wu; Karthik Mallilankaraman; Radoslaw Mikolaj Sobota; Yan Ting Lim; Loo Chien Wang; Chuan Keng Goh; Kai Xun Joshua Tay; Kwok Seng Loh; Cheng-I Wang; Wen-Hsien Lee; Boon Cher Goh; Chwee Ming Lim; Herbert Schwarz
Journal:  Cancer Immunol Immunother       Date:  2022-03-17       Impact factor: 6.630

Review 4.  Epithelial-Mesenchymal Plasticity in Tumor Immune Evasion.

Authors:  Riley D Z Mullins; Ananya Pal; Thomas F Barrett; Molly E Heft Neal; Sidharth V Puram
Journal:  Cancer Res       Date:  2022-07-05       Impact factor: 13.312

5.  The ERBB network facilitates KRAS-driven lung tumorigenesis.

Authors:  Björn Kruspig; Tiziana Monteverde; Sarah Neidler; Andreas Hock; Emma Kerr; Colin Nixon; William Clark; Ann Hedley; Sarah Laing; Seth B Coffelt; John Le Quesne; Craig Dick; Karen H Vousden; Carla P Martins; Daniel J Murphy
Journal:  Sci Transl Med       Date:  2018-06-20       Impact factor: 17.956

6.  LAMC2 promotes cancer progression and gemcitabine resistance through modulation of EMT and ATP-binding cassette transporters in pancreatic ductal adenocarcinoma.

Authors:  Yasuyuki Okada; Naoki Takahashi; Tetsuji Takayama; Ajay Goel
Journal:  Carcinogenesis       Date:  2021-04-30       Impact factor: 4.944

7.  Cul4A-DDB1-mediated monoubiquitination of phosphoglycerate dehydrogenase promotes colorectal cancer metastasis via increased S-adenosylmethionine.

Authors:  Yajuan Zhang; Hua Yu; Jie Zhang; Hong Gao; Siyao Wang; Shuxian Li; Ping Wei; Ji Liang; Guanzhen Yu; Xiongjun Wang; Xinxiang Li; Dawei Li; Weiwei Yang
Journal:  J Clin Invest       Date:  2021-11-01       Impact factor: 14.808

8.  Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer.

Authors:  D Korbakis; A Dimitromanolakis; I Prassas; G J Davis; E Barber; K L Reckamp; I Blasutig; E P Diamandis
Journal:  Br J Cancer       Date:  2015-07-16       Impact factor: 7.640

9.  Molecular Portrait of Oral Tongue Squamous Cell Carcinoma Shown by Integrative Meta-Analysis of Expression Profiles with Validations.

Authors:  Soundara Viveka Thangaraj; Vidyarani Shyamsundar; Arvind Krishnamurthy; Pratibha Ramani; Kumaresan Ganesan; Muthulakshmi Muthuswami; Vijayalakshmi Ramshankar
Journal:  PLoS One       Date:  2016-06-09       Impact factor: 3.240

10.  Interaction between laminin-5γ2 and integrin β1 promotes the tumor budding of colorectal cancer via the activation of Yes-associated proteins.

Authors:  Bijiao Zhou; Shumin Zong; Weilong Zhong; Yixuan Tian; Lumeng Wang; Qian Zhang; Renya Zhang; Lei Li; Wei Wang; Jianmin Zhao; Xin Chen; Yaju Feng; Binghui Zhai; Tao Sun; Yanrong Liu
Journal:  Oncogene       Date:  2019-11-01       Impact factor: 8.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.